63 related articles for article (PubMed ID: 10623576)
1. Selective inhibition of human lung cancer cell growth by peptides derived from retinoblastoma protein.
Radulescu RT; Jaques G
Biochem Biophys Res Commun; 2000 Jan; 267(1):71-6. PubMed ID: 10623576
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein.
Antelman D; Machemer T; Huyghe BG; Shepard HM; Maneval D; Johnson DE
Oncogene; 1995 Feb; 10(4):697-704. PubMed ID: 7862447
[TBL] [Abstract][Full Text] [Related]
3. Potent in vivo antineoplastic activity of MCR peptides MCR-4 and MCR-14 against chemotherapy-resistant human small cell lung cancer.
Radulescu RT; Jaques G
Drugs Exp Clin Res; 2003; 29(2):69-74. PubMed ID: 12951836
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma protein in non-small cell lung carcinoma, cells arrested for growth by retinoic acid.
Maxwell SA
Anticancer Res; 1994; 14(4A):1535-40. PubMed ID: 7979182
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.
Xu HJ; Zhou Y; Seigne J; Perng GS; Mixon M; Zhang C; Li J; Benedict WF; Hu SX
Cancer Res; 1996 May; 56(10):2245-9. PubMed ID: 8625292
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma deficiency increases chemosensitivity in lung cancer.
Zagorski WA; Knudsen ES; Reed MF
Cancer Res; 2007 Sep; 67(17):8264-73. PubMed ID: 17804741
[TBL] [Abstract][Full Text] [Related]
9. The hollow fiber assay: continued characterization with novel approaches.
Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
11. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
Sharma G; Singh RP; Chan DC; Agarwal R
Anticancer Res; 2003; 23(3B):2649-55. PubMed ID: 12894553
[TBL] [Abstract][Full Text] [Related]
12. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
Osborne AR; Zhang H; Blanck G
Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human retinoblastoma protein inhibits cancer cell growth.
Pagliaro LC; Antelman D; Johnson DE; Machemer T; McCulloch EA; Freireich EJ; Stass SA; Shepard HM; Maneval D; Gutterman JU
Cell Growth Differ; 1995 Jun; 6(6):673-80. PubMed ID: 7669721
[TBL] [Abstract][Full Text] [Related]
16. Effect of restoration of retinoblastoma gene function on the radiosensitivity of cells of human tumor cell lines.
Tsang NM; Little JB
Radiat Res; 1994 Nov; 140(2):172-9. PubMed ID: 7938465
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.
Johnstone SA; Gelmon K; Mayer LD; Hancock RE; Bally MB
Anticancer Drug Des; 2000 Apr; 15(2):151-60. PubMed ID: 10901303
[TBL] [Abstract][Full Text] [Related]
18. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein.
Radulescu RT; Bellitti MR; Ruvo M; Cassani G; Fassina G
Biochem Biophys Res Commun; 1995 Jan; 206(1):97-102. PubMed ID: 7818556
[TBL] [Abstract][Full Text] [Related]
19. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
20. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
